> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA OKs Takeda’s Dexilant SoluTab
- URL: https://www.fdaweb.com/fda-oks-takedas-dexilant-solutab/
- Published: 2016-01-27T12:00:00.000Z
- Updated: 2026-09-15T02:31:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5134583

> FDA has approved a Takeda Pharmaceuticals NDA for Dexilant SoluTab (dexlansoprazole) delayed-release orally disintegrating tablets, a new formulation of the drug that can be taken by allowing the tablet to melt in a patient’s mouth. Dexilant SoluTab is a proton pump inhibitor indicated for treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease and the maintenance of healed erosive esophagitis and relief of heartburn in adults 18 years and older.